Secalonic acid D-induced changes in palatal cyclic AMP and cyclic GMP in developing mice

Area of Science:

• Developmental Biology
• Toxicology
• Biochemistry

Background:

• Secalonic acid D (SAD) is a known teratogen that induces cleft palate in developing mouse embryos.
• The precise molecular mechanisms underlying SAD-induced teratogenesis remain largely unknown.
• Cyclic nucleotides, specifically cAMP and cGMP, play crucial roles in cellular signaling and embryonic development.

Purpose of the Study:

• To investigate the role of cyclic nucleotides (cAMP and cGMP) in the teratogenic effects of Secalonic acid D (SAD) on palate development.
• To determine if SAD exposure alters endogenous cAMP and cGMP levels during critical stages of mouse palate formation.

Main Methods:

• Pregnant CD-1 mice were administered SAD or a control vehicle on day 11 of gestation.
• Fetal palates were collected at various gestational ages (days 13-16).
• Radioimmunoassay (RIA) was employed to quantify cAMP and cGMP levels in fetal palate extracts.

Main Results:

• SAD exposure led to significant alterations in both cAMP and cGMP levels during palate development, with initial decreases followed by later increases.
• Specifically, SAD decreased cAMP on days 13-14 and increased it on day 15, while cGMP levels showed a decrease on day 13 and a significant increase on days 15-16.
• These dynamic changes in cyclic nucleotide levels correlated with a high incidence of cleft palate (20-34%) and morphological defects, including failed shelf elevation, in SAD-treated fetuses.

Conclusions:

• The induction of cleft palate by Secalonic acid D is associated with significant, dynamic alterations in fetal palate cAMP and cGMP levels.
• These findings support a mechanistic role for cyclic nucleotide-mediated cellular processes in both normal and SAD-induced abnormal palate development.